Stay updated on Safety of Doxorubicin & Pembrolizumab in Sarcoma Clinical Trial

Sign up to get notified when there's something new on the Safety of Doxorubicin & Pembrolizumab in Sarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of Doxorubicin & Pembrolizumab in Sarcoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Major update: new operating-status notice and a v3.2.0 version appears, replacing the old v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T05:57:42.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:11:34.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2. The 'Back to Top' UI element was removed; this is a minor change and the substantive update is the new release version.
    Difference
    0.2%
    Check dated 2025-09-14T19:52:01.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-07T16:49:29.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as new information on various medical compounds and treatments related to soft tissue sarcoma. Notably, the revision number has been updated to v3.0.0.
    Difference
    2%
    Check dated 2025-08-31T12:09:57.000Z thumbnail image
  8. Check
    58 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-08-17T04:38:43.000Z thumbnail image

Stay in the know with updates to Safety of Doxorubicin & Pembrolizumab in Sarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of Doxorubicin & Pembrolizumab in Sarcoma Clinical Trial page.